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E-mail address: bairong.shen@suda.edu.cn (B. SheCancer is a malignant disease that has causedmillions of human deaths. Its study has a long history of well
over 100 years. There have been an enormous number of publications on cancer research. This integrated
but unstructured biomedical text is of great value for cancer diagnostics, treatment, and prevention. The
immense body and rapid growth of biomedical text on cancer has led to the appearance of a large number
of textmining techniques aimed at extracting novel knowledge from scientiﬁc text. Biomedical textmining
on cancer research is computationally automatic and high-throughput in nature. However, it is error-prone
due to the complexity of natural language processing. In this review, we introduce the basic concepts
underlying text mining and examine some frequently used algorithms, tools, and data sets, as well as
assessing howmuch these algorithms have been utilized.We then discuss the current state-of-the-art text
mining applications in cancer research and we also provide some resources for cancer text mining. With
the development of systems biology, researchers tend to understand complex biomedical systems from
a systems biology viewpoint. Thus, the full utilization of text mining to facilitate cancer systems biology
research is fast becoming a major concern. To address this issue, we describe the general workﬂow of text
mining in cancer systems biology and each phase of theworkﬂow.We hope that this review can (i) provide
a useful overview of the current work of this ﬁeld; (ii) help researchers to choose text mining tools and
datasets; and (iii) highlight how to apply text mining to assist cancer systems biology research.
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The vast numbers of biomedical text provide a rich source of
knowledge for biomedical research. Text mining can help us to
mine information and knowledge from a mountain of text and it
is now widely applied in biomedical research. As shown in
Fig. 1A, the number of publications obtained from PubMed using
‘‘text mining’’ as the query word in the title or abstract has grown
substantially since 2000. Many researchers have taken advantage
of text mining technology to discover novel knowledge to improve
the development of biomedical research, especially those pertain-
ing to malignant diseases, such as cancer.
As a notoriously lethal human disease, cancer caused 7.4 mil-
lion deaths in 2008 [1]. Thus, cancer is one of the most important
study areas for biomedical researchers. It has been widely studied
for more than 100 years. The huge body and rapid growth of text
on cancer research provides a valuable resource. As can be seen
in Fig. 1B, there are many publications on cancer research and
the number of publications keeps increasing every year. We
searched PubMed with ‘‘cancer’’ in the title or abstract and we re-
trieved more than 847,000 publications. It is almost impossible for
people to read all of these publications and discover new knowl-
edge. Text mining is able to help researchers to complete this dif-
ﬁcult task. Realizing the advantages of text mining will facilitate
cancer research, by helping to ﬁnd new knowledge for cancer diag-
nostics, treatment, and prevention.
Text mining employs many computational technologies, such as
machine learning, natural language processing, biostatistics, infor-
mation technology, and pattern recognition, to ﬁnd new exciting
outcomes hidden in unstructured biomedical text. There are manyFig. 1A. The number of publications in PubMed using the query word ‘‘text mining’’
or ‘‘literature mining’’ in the title or abstract. Search detail: text mining [Title/
Abstract] OR literature mining [Title/Abstract].
Fig. 1B. The number of publications in PubMed using the query word ‘‘capplications of cancer-related text mining, such as identifying
malignant tumor related biomedical mentions (genes, proteins,
etc.), ﬁnding relationships among biomedical entities (protein–
protein, gene–disease, etc.), extracting knowledge from text and
generating hypotheses, and constructing or improving pathways.
Several review articles for biomedical text mining have been pub-
lished in past years [2–8], in this review, we pay much attention to
the application of text mining in cancer research.
In the following, we introduce the fundamental concepts and
tasks of text mining. We address some representative algorithms
for each major task in text mining and we discuss at great lengths
how far these algorithms have been utilized in biomedical text
mining. We then present some state-of-the-art text mining appli-
cations and datasets, especially those developed for the genomic
era. We review work that has applied text mining techniques to
cancer research and some resources for cancer text mining. Finally,
we highlight the general workﬂow of text mining during cancer
systems biology and talk about each phase in detail.
2. Biomedical text mining phases and tasks
The goal of textmining is to derive implicit knowledge that hides
in unstructured text and present it in an explicit form. This gener-
ally has four phases: information retrieval, information extraction,
knowledge discovery, and hypothesis generation. Information re-
trieval systems aim to get desired text on a certain topic; informa-
tion extraction systems are used to extract predeﬁned types of
information such as relation extraction; knowledge discovery sys-
tems help us to extract novel knowledge from text; hypothesis gen-
eration systems infer unknown biomedical facts based on text, as
shown in Fig. 2. Thus, the general tasks of biomedical text mining
include information retrieval, named entity recognition and rela-
tion extraction, knowledge discovery and hypothesis generation.
2.1. Information retrieval
Besides conventional information retrieval systems, there are
also advanced knowledge information retrieval systems that inte-
grate data from different resources into a single context to enhance
our understanding of complex biomedical systems. For example, to
access text mining results and other data, Maier et al. [9] generated
a chronic obstructive pulmonary disease knowledge base and
developed an integrated knowledge management systems. Sali-
vaomics Knowledge Base [10] deﬁned the Saliva Ontology as a
terms and relations vocabulary to facilitate data retrieval and inte-
gration across multiple ﬁelds of research together with data anal-
ysis and data mining. QuExT [11], a PubMed-based document
retrieval system, followed a concept-oriented query expansion
methodology to ﬁnd documents containing concepts related toancer’’ in the title or abstract. Search detail: cancer [Title/Abstract].
Fig. 2. Conventional phases and tasks involved in biomedical text mining.
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and high-throughput methods for gene analysis, there will be a
continually growing need for text mining and information retrieval
tools to help researchers ﬁnd relevant articles for their studies.
2.2. Named entity recognition and relation extraction
Named entity recognition is the most important step in the
extraction of knowledge [12], which has the overall aim of identi-
fying speciﬁc terms, such as gene, protein, disease, and drug. Sev-
eral technologies in computing have been employed for
biomedical term identiﬁcation. However, in practice, there are still
many obstacles for automatically identifying biomedical terms. For
example, a biomedical term may have several different written
forms, e.g., epilepsy and falling sickness refer to the same disease,
which is a disorder of the central nervous system characterized by
the loss of consciousness and convulsions [13]. In addition, an en-
tity can be represented differently, e.g., cancer can be represented
as a disease as well as an astronomical sign. Moreover, abbrevia-
tions of terms can cause ambiguity problems. For example, PC
may mean prostate cancer, phosphatidyl choline, or even personal
computer. Many biomedical terms also consist of phrases or com-
pound words, or they may have an afﬁx.
Current biomedical namedentity recognition technique falls into
threemajor categories:dictionary-basedapproaches, rule-basedap-
proaches andmachine learning approaches [2,14]. However, dictio-
nary-based approaches tends to miss undeﬁned terms that are not
mentioned in the dictionary [15], rule-based approaches require
rules that identify terms from text, and the resulting rules are often
not effective in all cases [15].Machine learningapproachesgenerally
require standard annotated training data sets which usually takes
tremendous human efforts to build [16]. Moreover, most machine
learning approaches tend to be data-driven and application do-
main-oriented and precision, recall rate, and F1 rate are often used
to evaluate the performance of the recognition, as follows [17]:
precision ¼ number of true positive
number of true positiveþ number of false positive ð1Þ
recall ¼ number of true positive
number of true positiveþ number of false negative ð2Þ
F1 ¼ 2  precision  recallprecisionþ recall ð3ÞFor example, when we identify a gene term, true positive refers to a
gene term is correctly identiﬁed as a gene; false positive indicates a
non-gene term is incorrectly identiﬁed as a gene, and false negative
incorrectly identiﬁes a gene term as non-gene term.
Machine learning approaches are now used widely for named
entity recognition, e.g., Hidden Markov Models (HMM) [18], Sup-
port Vector Machines (SVMs) [19], Conditional Random Fields
(CRFs) [20], and Maximum Entropy (ME) [21]. For examples, Zhou
et al. [22] used an HMM-based system with biomedical informa-
tion as domain knowledge to recognize protein, DNA, RNA,
cell-type, and cell-line. Kazama et al. [23] used SVMs to identify
protein, DNA, cell-type, cell-line, and lipid, with a 73.6% F1 rate.
Tsai et al. [24] developed a CRFs system to extract protein men-
tions, achieving a 78.4% F1 rate. Lin et al. [25] used ME to recognize
23 categories of biological terms with a 72% F1 rate.
Presently, the best F1 rates for biomedical named entity recog-
nition systems are not as good as the results from general purpose
ones [26]. Researchers have tried many methods to improve the
performance, by combining different approaches and proposing
hybrid approaches [27], conducting post-processing after machine
learning, and adding biomedical domain knowledge [28,29]. Some
of these applications are discussed in the following section.
A biomedical term may appear in the form of abbreviation and
may also have multiple synonyms in text. Abbreviation recognition
and synonym recognition are helpful for unifying and normalizing
biomedical terms in named entity recognition. There are many
such systems. For example, Chang et al. [30] used logistic regres-
sion to score abbreviations and obtained an 83% recall rate and
80% precision rate with the Medstract corpus. An abbreviation rec-
ognition system was developed in [31], based on a machine learn-
ing approach, with a 95.86% precision rate and an 84.64% recall
rate with the AB3P corpus. Yu et al. [32] developed a set of pat-
tern-matching rules to map an abbreviation to its full form and
achieved a 70% recall rate and a 95% precision rate. Based on collo-
cations, Liu and Friedman’s system [33] achieved an 88.5% recall
rate and a 96.3% precision rate. McCrae and Collier [34] developed
a rule-based synonym recognition system, and the system imple-
mented by Cohen et al. [35] was based on pattern extraction.
More current research is now interested in terms identiﬁcation
and normalization [36]. One of the tasks in BioCreative III is fo-
cused on gene normalization, which identiﬁes gene mentions and
links these genes to standard identiﬁers (e.g., database identiﬁers)
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developed by Liu et al. [38].
Conventional relationship extraction is focused on investigating
biomedical relation extraction (e.g., protein–protein interaction
and gene–disease relation) from biomedical terms (e.g., genes, pro-
teins, diseases, or drugs) [39]. Many researchers have done much
work on relationship extraction. The system developed by Ben
Abacha et al. [40] is able to identify the correct semantic relation-
ship between each pair of entities using MetaMap [41] to identify
medical substances while a linguistic patterns approach deter-
mines the semantic relationship between each pair. The systems
developed by Chun et al. [42] could extract gene–disease relations
from Medline. They used a machine learning-based named entity
recognition system to remove incorrect disease and gene names
caused by dictionary matching-based term recognition. They found
that improving the terms recognition performance could also im-
prove the relationship extraction precision.
In the current genomic era, many researchers are interested in
mining gene–gene interactions, protein–protein interactions, and
other interactions in genome-wide associations that provide useful
scaffolds for further integrative analysis of gene expression and
database annotation [2,43–45], as well as other extensive relation-
ships [16]. Eskin and Agichtein [46] applied text mining technology
and combined it with sequence analysis to discover protein sub-
cellular localizations, and the results seemed to be highly accurate.
Li et al. [47] took a co-occurrence-based text mining approach to
determine interactions from the biomedical literature where they
used a naïve Bayesian approach to verify the resulting interactions
by integrating heterogeneous types of evidence from genomic and
proteomic data sets. The systems developed by Agarwal et al. [17]
can be used to determine whether an article is related to protein–
protein interactions and to map the interaction to relevant articles.
Tsai [48] presented a text mining and visualization framework to
ﬁnd the details of protein–protein interactions and provide a dee-
per understanding of protein function by identifying the sequence
of amino acids at the interface of a protein interaction.
In addition, researchers are focusing on the relationship
between genes and other biomedical entities, as well as the rela-
tionship between proteins and other biomedical entities, such as
gene–disease relationships and protein sub-cellular relationships.
For example, the system developed by Krallinger et al. [49] can sys-
tematically access information to analyze genetic, cellular, and
molecular aspects of the plant Arabidopsis thaliana. Srinivasan
and Wedemeyer [50] studied the relationship between diseases
and disease areas. Shetty and Dalal [51] constructed a statistical
document classiﬁer that was based on MEDLINE citations to deter-
mine whether a drug had caused adverse effects. Their systems
contributed to current drug safety procedure.
2.3. Knowledge discovery
Knowledge including facts, information, or descriptions, impli-
cit or explicit, refers to the theoretical or practical understanding
of a domain or a subject [52]. Knowledge discovery is the creation
of knowledge from large volumes of structured or unstructured
data. The knowledge obtained may become additional data that
can be used for further usage and discovery [53]. Knowledge dis-
covery is a very important part of data mining. Text mining, also
referred as text data mining, is a branch of data mining that partic-
ularly deals with text. Discovering knowledge from biomedical text
is a process with the aims to ﬁnd answers for biomedical questions,
such as identifying new drug targets or novel cancer diagnostic
biomarkers. The CRAB, a fully integrated text mining tool devel-
oped by Korhonen et al. [54], extracted relevant data in literature
and assessed cancer risk by utilizing knowledge discovery technol-
ogies. Their work demonstrated that text mining pipeline can facil-itate complex research tasks in biomedicine. In addition, Nam and
Park [55] took advantage of text mining to integrate existed work
and discovered two pathways functionally involved in the predic-
tor gene set indicative of susceptibility to early-onset colorectal
cancer, overcoming shortage of whole-genome expression studies
of colorectal cancer.
Knowledge discovery is able to integrate biomedical text with
other multiple sources of data to generate a novel interpretive con-
text [56]. For example, through text mining technology together
with microarray data, Urzua et al. [57] found out post-transcrip-
tional control of ovarian processes as possible cause for the ob-
served tumor and reproductive phenotypes. They also inferred
that it was repetitive cycling that represented the actual link be-
tween ovarian tumorigenesis and reproductive records [57].2.4. Hypothesis generation
Based on facts or information that cannot be satisfactorily ex-
plained with the available knowledge, a scientiﬁc hypothesis,
which is a trial solution to a problem rather than a theory, can
be proposed for suggestion on further research [58]. Experiments
may be used to evaluate the proposed hypotheses before solving
the problem. Scientiﬁc hypothesis is somewhat like a scientiﬁc
imagination which is based on existing evidence and knowledge.
As it says, imagination is so important that it embraces the entire
world, and all there ever will be to know and understand. Hypoth-
esis generation is to get unproved inference with clues hidden in
the text while knowledge discovery means to extract novel
knowledge.
The biomedical literature is a treasure trove of potential infor-
mation for making biomedical inferences and generating new
hypotheses. Hypothesis generation is an important task in text
mining, which is very helpful for biomedical researchers who want
to infer unknown biomedical facts that can be used to guide the de-
sign of experiments or explain existing experimental results. This
task is gradually receiving much more attention from researchers.
Swanson [59] used a pattern rule to determine a hidden link be-
tween ﬁsh oil and Raynaud’s syndrome in published text. Li et al.
[60] built Alzheimer’s Disease-speciﬁc drug–protein connectivity
maps based on protein interaction networks and literature mining.
By exploring the Alzheimer’s disease connectivity map, they pro-
posed a new hypothesis that diltiazem and quinidinemay be inves-
tigated as candidate drugs for Alzheimer’s disease treatment.
Hettne et al. [61,62] used an association-based technique and a nat-
ural language processing tool to generate a ranked list of genes
associated with diseases and extracted the relations between genes
and lipopolysaccharide. Topinka and Shyu [63], taking an biomedi-
cal text mining based approach, along with structure-based pro-
tein–protein interaction, predicted cancer interaction networks.3. Data sets and tools for biomedical text mining
In terms of information retrieval systems, PubMed [64,65] is
one of the best known biomedical databases and it contains more
than 20 million citations on biomedical articles from MEDLINE and
life science journals, which provides a convenient web-based
search portal for users as well as an application program interface
for developers. Textpresso [66,67] uses an ontology, returns
searching goals for classes of biological concepts (e.g., gene, allele,
cell, or phenotype), classes of relations of objects (e.g., association,
regulation), and related descriptions (e.g., biological process).
GoPubMed [68,69] classiﬁes literature abstracts according to a
Gene Ontology and shows the ontology terms that are related to
the query words. In addition, it allows users to explore PubMed
search results with an ontology viewer.
Table 1
Some frequently used biomedical named entity recognition systems.
System Brief introduction
ABNER [130,131] ABNER is a software tool for molecular biology text analysis. It uses linear-chain conditional random ﬁelds approach with orthographic and
contextual features
GENIATagger [132,133] The GENIA tagger is speciﬁcally tuned for biomedical text such as MEDLINE abstracts. It is a useful pre-processing tool for information
extraction from biomedical documents
LingPipe [134–136] LingPipe provides three generic, trainable chunkers to carry on named entity recognition. LingPipe can be used to identify biomedical entities
such as genes, organisms, malignancies, and chemicals
Yapex [137,138] Yapex is a rule-based system named entity recognition system that utilizes lexical and syntactic analysis to identify protein names
Table 2
Standard annotated data sets for biomedical named entity recognition.
Corpus name Brief introduction
Acromine [139,140] The abbreviation dictionary of Acromine is automatically constructed from the whole MEDLINE. Acromine showed it was quite good then it
was applied to the whole MEDLINE
BioLexicon [94] The BioLexicon brings together terminologies from several large public bioinformatics data resources such as UniProtKb, ChEBI and NCBI. The
BioLexicon represents terms in conjunction with lexical and statistical information so as to improve performance of text mining
GENETAG [141,142] GENETAG is one of the most important standardized standard data sets for biomedical named entity recognition testing. It has 20,000
MEDLINE sentences for gene/protein term identiﬁcation. 1, 5000 GENETAG sentences were used for the BioCreAtIvE Task 1A Competition
GO [143] The Gene Ontology (GO) project is a major bioinformatics initiative aiming at standardizing the representation of gene and gene product. GO
provides a controlled vocabulary of terms for describing gene product characteristics and gene product annotation data
Table 3
Some useful tools for relationship extraction.
System Brief introduction
BCMS [144,145] BioCreative MetaServer (BCMS) is a meta-service for information extraction which can generate annotations for PubMed/Medline abstracts,
covering gene names, gene IDs, species, and protein–protein interactions
Chilibot [146,147] Chilibot searches PubMed abstracts about speciﬁc relationships between proteins, genes, or keywords. The results are returned as a graph
HPID [148,149] The Human Protein Interaction Database (HPID) provides human protein interaction information from existing structural and experimental
data, and integrated human protein interactions derived from BIND, DIP and HPRD. Users can ﬁnd potential interaction between with input
protein and proteins of the databases. The protein IDs in EMBL, Ensembl, MIM, RefSeq, HPRD and NCBI can be used during interaction search
HPRD [150–152] The Human Protein Reference Database (HPRD) is a platform for human protein interaction networks and disease association. All the
information in HPRD has been manually extracted from the literature by experts. For each in the proteome. HPRD can visually deploy the
results
iHOP [70,71,153] Information Hyperlinked over Proteins (iHOP) can generate a network of concurring genes and proteins from millions of PubMed abstracts.
iHOP utilizes genes and proteins as hyperlinks between sentences and abstracts; hence the information can be converted into an integrated
navigable resource
IntAct [154,155] IntAct provides analysis tools for molecular interaction as well as interaction database of which data were derived from literature curation or
user submissions
MedScan [156,157] MedScan collected information and data retrieval from multiple sources of public information, text, journals, and various datasets, and then
transformed into biological relationships which could be used for hypothesis generating and veriﬁcation, disease understanding, drug and
patient management
PubGene [158,159] The retrieve names of gene and protein by PubGene are cross-referenced to each other and to relevant terms with goal of understanding
biological function, importance in disease and their relationship
Reactome [160–162] Reactome is an open-source data analysis tools, as well as a manually curated and peer-reviewed database including interaction, reaction and
pathway data. Reactome can be used for interaction, reaction and pathway-based analysis
Table 4
Some standard annotated data sets for relation extraction.
Data set name Brief introduction
BioInfer [163–165] BioInfer is a XML-based format corpus protein–protein interaction. The data of BioInfer were from ﬁve well-known protein–protein
interaction corpora: AIMed, BioInfer, LLL, IEPA, and HPRD50
HIV-1, human PI [166–169] HIV-1 corpus contains summary of all known interactions of HIV-1 proteins with host cell proteins, other HIV-1 proteins, or proteins
from disease organisms associated with HIV/AIDS
LLL 05 [170] The LLL05 is composed by annotation indicating agent and target of a gene interaction, a dictionary of named entities as well as variants
and synonyms, and linguistic information. The LLL05 can be used to evaluate the ability of systems to identify gene/proteins interactions
PICorpus [171,172] PICorpus is a protein–protein interaction corpus which was originally created at the PDG. PICorpus can be used for a variety of
biomedical text mining tasks, such as named entity extraction, relation identiﬁcation and relation extraction systems
PDZBase [173,174] PDZBase contains 339 PDZ-domain mediated protein–protein interactions, which have been manually extracted. All the interactions are
mediated directly by the PDZ-domain, and identiﬁed in vivo or in vitro experiments. The information of the binding-sites of interacting
proteins are known.
STRING [175,176] STRING provides known and predicted protein interactions, including physical and functional associations derived from Genomic
context, high-throughput experiments, coexpression and previous knowledge
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Table 5
Some commonly used standard annotated data sets for text mining.
Data set name Brief introduction
BioCreative III [177] BioCreative III works for evaluating text mining and information extraction systems applied to the biomedical domain. BioCreative III has
several data set for three tasks: cross-species gene identiﬁcation and normalization, protein–protein interactions extraction, and interactive
demonstration task for gene indexing and retrieval task
BioInfer [163–165] BioInfer is a XML-based format corpus protein–protein interaction. The data of BioInfer were from ﬁve well-known protein–protein interaction
corpora: AIMed, BioInfer, LLL, IEPA, and HPRD50
BioText [178–184] BioText was initially constructed by 1000 randomly selected MEDLINE abstracts from the results of a query on the term yeast. The dataset was
then manually annotated and further veriﬁed. BioText has 954 correct pairs, including abbreviation deﬁnitions, protein–protein interaction
data, and relations between disease treatment entities
GENIA [185,186] The GENIA data set is one of the most frequently used dataset for evaluation of biomedical and biological information extraction and text
mining systems. The data set contains 1999 Medline abstracts, selected using a PubMed query for terms human, blood cells, and transcription
factors
The GENIA data set has many sub data set, aiming for part-of-Speech annotation, constituency (phrase structure) syntactic annotation, term
annotation, event annotation, relation annotation, and coreference annotation
PICorpus [171,172] PICorpus is a protein–protein interaction corpus which was originally created at the PDG. PICorpus can be used for a variety of biomedical text
mining tasks, such as named entity extraction, relation identiﬁcation and relation extraction systems
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powerful systems and data sets. Table 1 provides a list of some use-
ful biomedical named entity recognition systems. Table 2 lists
standard data sets that can be used to evaluate the performance
of a named entity recognition system or to develop a machine
learning-based named entity recognition system. Tables 1 and 2
also have some synonym and abbreviation recognition systems
and resources.
There are many useful relationship extraction systems, such as
iHOP [70,71], which detects the interactions between genes by
using genes or proteins as hyperlinks between sentences and ab-
stracts based on a co-occurrence approach. More relationship
extraction systems are shown in Table 3.
To overcome the lack of integration between genomic data and
biological literature, Baran et al. [72] developed a tool that linked
over 2 million articles in PubMed to nearly 150,000 genes in
Ensembl from 50 species. The data set for relationship extraction
is also important. Some common data sets are shown in Table 4. Fi-
nally, some commonly used standard annotated data sets for text
mining purposes are listed in Table 5.
Many hypothesis generation systems are available. BioText-
Quest [73] is a biomedical text mining system for concept discov-
ery that provides services such as biomedical named entity
recognition, concept association, and hypothesis generation.
Arrowsmith [74,75] identiﬁed meaningful links between two sets
of Medline articles. BITOLA [76–78] can be used to mine new dis-
coveries among biomedical entities or concepts, such as disease
candidate gene in the literature.4. Application of biomedical text mining in cancer research
There is a vast body of work on biomedical text mining in can-
cer research. In particular, DNA methylation is one of the hottest
topics. Methylation proﬁles have been successfully used for the
early detection and personalized treatment of cancer [79,80]. Dif-
ferent databases have been developed for DNA methylation. Pub-
Meth [81] and MeInfoText [79,80] are the two most popular
databases in this area. PubMeth [81] is a cancer methylation data-
base with text mining tools and expert annotations. Associations
among genes, methylation, and cancers in MeInfoText [79,80] are
extracted from a large body of biomedical literature.
As a complex disease, cancer is related to a large number of
genes and proteins. Biomedical researchers are interested in min-
ing cancer-related genes and proteins from the literature to study
cancer diagnostics, treatment, and prevention. Chun et al. [82]
developed maximum entropy-based system that recognizes
named entities and the relationships among prostate cancer andrelevant genes. Deng et al. [83] employed a text mining approach
to identify prostate cancer-related genes as candidate genes and
they used the OMIM (Online Mendelian Inheritance in Man) data-
base to verify them. Natarajan et al. [84] also built gene–gene
interaction networks for 72 genes using a text mining approach.
They discovered novel knowledge in the effect of S1P (sphingo-
sine-1-phosphate) on angiogenesis and the invasion of glioblas-
toma which contributed to understanding the interaction
between invasive glioblastoma and S1P. Krallinger et al. imple-
mented two cancer-related text mining applications [85]. One
was used to extract human gene mutations of predeﬁned types
of cancer from literatures; the other was particularly used for
breast cancer categorization and text-based breast cancer gene
ranking. Clancy et al. [86] developed a ranked immunological rele-
vance score for all human genes, which is used to evaluate gene
expression proﬁles and quantify the immunological component
of tumors. They applied it to expression proﬁles in melanomas to
ﬁnd the early activation of the adaptive immune response and
the diversity of the immune component during melanoma
progression.
Other biomedical interactions are also important areas for can-
cer researchers. Kolluru et al. [87] used text mining workﬂows to
automatically extract substances from microorganisms and their
habitats in free text. They used conditional random ﬁelds to extract
microorganisms, habitats, and the inter-relationships between
organisms and their habitats from the literature. Xu et al. [88] uti-
lized scientiﬁc literature from PubMed to extract experimental
data on protein phosphorylation. The resulting information proved
to be valuable for biomedical researchers studying cellular pro-
cesses and cancers. PESCADOR, a web-based tool for text mining,
can be used to extract network of interactions from PubMed ab-
stracts, and reﬁne the interaction network in accordance with
user-deﬁned concepts [89]. It has been applied in the exploring
protein aggregation in neurodegenerative disease and in the
expansion of pathways associated with colon cancer [89].
It is believed that early detection, evidence-based strategies for
prevention and patient management can be used to reduce and
control the causes of cancer. Thus, an important part of cancer re-
search is cancer risk assessment, which determines the likelihood
of developing cancer by evaluating the available evidence. Korho-
nen et al. [90] applied biomedical text mining technology to cancer
risk assessment. They extracted evidence from the literature as fea-
tures and developed several classes for risk levels of the causes of
cancer, from which researchers can acquire the risk levels. Guo
et al. [91] developed classiﬁers for the automatic identiﬁcation of
schemes from abstracts to help cancer risk assessment.
Clinical records normally include an abundance of information
on disease diagnosis and treatment, so it is possible to use them
Fig. 3. An illustration of a text mining-assisted cancer study workﬂow from a systems biology viewpoint.
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Abacha et al. [40] used a supervised machine learning approach
to extract the relationships among medical problems, treatments,
and tests. You et al. [92] proposed a multi-class classiﬁer to analyze
diagnostic syndromes in the clinical records to improve experience
and techniques. Lee et al. [93] developed a text mining based sys-
tem to discover the relationships among cancer and potential fac-
tors. They mined relationships among diseases and potential
factors in clinical medical records using self-organizing maps while
they used SVM to evaluate them.
There are several case studies in the context of text mining re-
sources for cancer research, such as the large-scale terminological
resources for biomedical text mining provided by Thompson et al.[94] that has over 2.2 million lexical entries and over 1.8 million
terminological variants, as well as over 3.3 million semantic rela-
tions, including over 2 million synonymy relations. In addition,
Thompson et al. [95] also provided an important resource for the
training of domain-speciﬁc information extraction systems, to
facilitate semantic-based searching of documents for interaction
extraction. Maqungo et al. [96] developed a database for prostate
cancer-associated genes. The database provides pre-compiled bio-
medical text mining information on prostate cancer and it also
integrates data on molecular interactions, pathways, gene ontolo-
gies, gene regulation at the molecular level, and predicted tran-
scription factor binding sites in the promoters of prostate cancer
implicated genes and transcription factors. The genes and miRNAs
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cer, were collected through text mining [97]. The database also
provides lung cancer associated networks for the further investiga-
tion of molecular mechanisms of lung cancer.5. Cancer systems biology research with text mining approach
5.1. Workﬂow of text mining based cancer systems biology research
Today, researchers tend to understand complex biological
systems from a systems biology viewpoint [98]. Systems biol-
ogy-based networks can be constructed by aggregating previously
reported associations from the literature or various databases. For
example, Hayasaka et al. [99] constructed a network of genes, ge-
netic diseases, and brain areas based on associations reported in
the literature. Sharma et al. [100] collected a set of known dis-
ease-related genes and built an interaction network by the min-
ing literature, ﬁnding 19 genes that were conﬁrmed to be
related to prostate cancer after analysis. Consequently, the full
utilization of text mining to facilitate cancer systems biology re-
search is a new hot topic. Generally the conventional ﬂow of text
mining based cancer systems biology research is text acquisition,
bio-entity terms recognition, complex relation extraction, new
knowledge discovery, and hypothesis generation in turn, as
showed in Fig. 3. We will discuss this procedure in detail in the
following.
In the general phase of text mining of cancer systems biology,
we initially obtained related biomedical text from many available
sources, such as PubMed. A number of literature databases provide
packed data download service. However, although it is convenient,
the included text is not timely updated, and text quantity is also
limited. Many literature database systems offers application pro-
gramming interface, by which we can use scripts to download
the text automatically by computers. For examples, through E-
utility of PubMed [64,101], users can easily get up-to-date text.
Named entity recognition tools can then be used to extract bio-
medical mentions from the text obtained. The mentions usually in-
clude terms such as gene names, protein names, mRNA (message
RNA) names, miRNA (micro-RNA) names, metabolism related
terms, and cell terms. After ﬁnding the biomedical terms, we can
build a gene–gene interaction network, metabolism pathways,
and other networks. Resources such as Gene Ontology can be used
for network building. MicroRNAs are considered to be connected
with cancer, so we can investigate howmiRNAs work in gene–gene
interaction. In the next phase, we can study how components and
structures change in dynamic contexts. Certain networks and their
variations, such as protein–protein interaction networks [102] and
variations in metabolism network, can be built from text. Due to
the high false negative rate in text mining-based networks, we
can employ some validation and inference algorithms to correct
and optimize the network. In each phase, we can use many re-
sources to validate the network, such as homology, co-expression
data, rich domain data, and co-biological process data, as well as
other information. Through validation, some nodes and interac-
tions with strong evidence will be strengthened, whereas a false
one will be removed or updated. Consequently, we can develop a
protein–protein interactome based on multiple sources of interac-
tion evidence [47]. Finally, all the networks and components can be
used for further studies.
Signaling pathway reconstruction plays a signiﬁcant role in
understand the molecular mechanisms in cancer. Signaling path-
way maps are usually obtained from manual literature search,
automated text mining, or canonical pathway databases [103].
Pena-Hernandez et al. implemented an extraction tool to ﬁnd gene
relationship and up-to-date pathways from literature [104].5.2. Examples of integrated biomedical text mining tools
An integrated biomedical text mining systems is supposed to
provide the stated functionalities. There are many tools dominated
in cancer research. However blindly using the results from text
mining tools is not a wise idea because the information and knowl-
edge derived from uncurated text are error prone. Many tools
choose to manually curate text by experts. In the following we will
brieﬂy introduce the three most popular commercial tools, i.e.,
Pathway Studio [105], GeneGO [106] and Ingenuity [107].
By Pathway Studio [105], we can analyze pathway, gene regula-
tion networks, protein interaction maps and navigate molecular
networks. Its background knowledge database contains more than
100,000 events of regulation, interaction and modiﬁcation be-
tween proteins, cell processes and small molecules. It has a natural
language processing module, MedScan, which enables Pathway
Studio for entity identiﬁcation and then applied handcrafted con-
text free grammar (CFG) rules to extract relationships. Pathway
Studio can access the entire PubMed database and online resource,
full-text journal, literature, experimental and electronic notebooks.
Pathways and networks from the extracted facts and interactions
extracted from retrieved text. Many algorithms such as Find direct
interactions, Find shortest paths, Find common targets or Find
common regulators are available.
MetaCore, one of key products of GeneGO [106] is an integrated
knowledge database and software suite for pathway analysis of
experimental data and gene lists. The knowledge base of MetaCore
is manually curated database derived from extensive full-text liter-
ature annotation. MetaMiner of GeneGo, mainly including MetaM-
iner Disease Platforms, MetaMiner Stem Cells, MetaMiner Prostate
Cancer, MetaMiner Cystic Fibrosis, offers a knowledge mining and
data analysis platforms for oncology. The most important disease
reconstruction function is based on three fundamentals, manual
annotation of all gene–disease associations, reconstruction of dis-
ease pathways and functional data and knowledge mining of
OMICs experimental studies published in a disease area. GeneGo
also provides API for third party software development.
Ingenuity [107] helps researchers model, analyze, and under-
stand the complex biomedical, biological and chemical systems
by integrating data from a variety of experimental platforms. One
application example of Ingenuity Systems is analysis of CD44hi
breast cancer stem cell-like subpopulations using Ingenuity iRe-
port. The base knowledge of Ingenuity is also extracted by experts
from the full text of the scientiﬁc literature, including ﬁndings
about genes, drugs, biomarkers, chemicals, cellular and disease pro-
cesses, and signaling and metabolic pathways. Researchers can
search the scientiﬁc literature and ﬁnd insights most relevant to
the desired experimental model or question, build dynamic path-
way models, and get conﬁdence in hypotheses and conclusions.6. Future work and challenges
With the development of the next-generation sequencing tech-
nologies, high throughput experimental methods are revolutioniz-
ing the life sciences rapidly. The widespread of the cloud
computing application is also accelerating the application of text
mining technology in the frontier research in life science. We here
discuss the work and challenges in the future application of text
mining in cancer researches as follows.
The ﬁrst challenge is to apply biomedical text mining technolo-
gies in the personalized medicine development. It is well-known
that cancer is a complex disease. Many factors such as race, gender,
age and environments may correlate with risk of cancer [108–114].
The personalized medicine is becoming a trend and the therapies
will be tailored to individual patients with their biomedical
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text mining technique to qualitatively identify the differences in
the focus of life review interviews by patient’s age, gender, disease
age and stage [115]. Ahmed et al. integrated compound–target
relationships related with cancer by text mining and presented
the spectrum of research on personalized medicine and com-
pound–target interactions [116]. The personalized medicine in
cancer will take in all these important aspects into consideration
during text mining [117]. One solution is to categorize data before
text mining rather than treat them together without any pre-
processing. It is a really tough task to categorize data at individual
level features. On the other hand, one of the negative consequence
of categorization is making it harder for text mining to ﬁnd a good
biomarker for all cases.
The second challenge is the complex of cancer molecular mech-
anisms. The same cancer phenotype could be caused by different
gene or gene sets from the same pathway or network. To study
the complex mechanisms of cancer, we need to mine text from a
hierarchical network view rather than from a single level. Systems
biomedicine carries on analysis and study from different levels,
including motif [118,119], pathway [120–122], module [123–
125] and network [126,127]. The resulting hierarchical data pro-
vide us valuable materials to conduct text mining on different lev-
els. However, how to correctly categorize text to hierarchical
network, and how to integrate text mining results from different
levels and discover new knowledge with a systems biomedicine
view are really a hard work.
The third challenge is to apply the text mining techniques in
translational medicine research. Translational medicine, an emerg-
ing ﬁeld of biomedicine, involves the transformation of laboratory
ﬁndings into novel diagnosis and treatment of patients [128]. The
knowledge of pre-clinical can be used in clinic to improve treat-
ment. Translational medicine facilitates the course of diseases pre-
dicting, preventing, diagnosing, and treating. Bioinformatics will be
a driver rather than a passenger for translational biomedical re-
search [128], such as the data integration and data mining platform
presented by Liekens et al. [129] could retrospectively conﬁrm re-
cently discovered disease genes and identify potential susceptibil-
ity genes. It will add tough tasks for text mining, since translation
biomedical text mining should consider various stages of informa-
tion and various sources of evidence, and integrate the Omics and
clinical data sets to ﬁnd out novel knowledge for both biology and
medicine domains. There are many this kind of applications, such
as the data integration and data mining platform presented by Lie-
kens et al. [129] could retrospectively conﬁrm recently discovered
disease genes and identify potential susceptibility genes.
The fourth challenge for textminingwill be the integration of the
text information atmolecule, cell, tissue, organ, individual and even
population levels to understand the complex biological systems.
Nevertheless, most of the current text mining studies focus on
molecular level, and very little text mining work reported at high
levels,which in fact has a close relationshipwith cancer phenotypes.
Text mining at high levels and integrate the text information at all
these levels will be a big challenge for cancer study and provide also
opportunities for successful cancer diagnosis and treatments.
The last challenge will be the de-noising and testing of the text
mining results. Text mining results are often obtained with noising
information and false positives since natural language text are of-
ten inconsistent. It contains ambiguities caused by semantics,
slang and syntax. It can be also suffered from noise and error in
text. As a result, the mined information cannot be used blindly.
Many methods have been developed to solve the problem. The ﬁrst
is to manually read and understand the contexts, analyze them,
and then add semantic tags. This pre-processing in fact turns the
unstructured text into structured text with semantic tags. Thereby,
the developed tools can easily achieve the goal with high precisionrate. However, the approach is very restricted as it needs vast hu-
man efforts and turns out to be very time consuming. As a result,
the data source for mining could be modest in size, only limiting
mining ability. The second method is to carry on text mining on
vast biomedical text, and then analyze the results and screen out
the ﬁnal results with prior domain experience. During the mining
process, domain knowledge is usually employed to improve min-
ing efﬁciency as well as the quality of the mined knowledge. This
approach although the mined results may still contain more errors,
is more powerful on knowledge discovering compared with the
ﬁrst approach. These two approaches are distinct on treating the
text to be mined. The ﬁrst one ensures correctness by carefully
manual pre-processing, while the second one is to select correct
ones by post-processing by experts. The third approach is to take
a compromise between pre-processing and post-processing, where
some advanced statistical analysis will be used to roughly clean
data at ﬁrst stage and then conduct mining on them.7. Conclusions
Currently, there is a huge body of biomedical text and their ra-
pid growth makes it impossible for researchers to address the
information manually. Researchers can use biomedical text mining
to discover new knowledge. We have reviewed the important re-
search issues related to text mining in the biomedical ﬁeld. We also
provided a review of the state-of-the-art applications and datasets
used for text mining in cancer research, thereby providing
researchers with the necessary resources to apply or develop text
mining tools in their research. We introduced the general work-
ﬂow of text mining to support cancer systems biology and we illus-
trated each phase in detail. We can see that text mining has been
used widely in cancer research. However, to fully utilize text min-
ing, it is still necessary to develop newmethods for full text mining
and for highly complex text, as well as platforms for integrating
other biomedical knowledge bases.
In spite of the huge potential of applying text mining on bio-
medicine, it still needs further development. Biomedical text min-
ing systems are not as golden standard tools of biomedical
researchers as retrieval systems and sequencing tools. The next
important mission of text mining for us is to develop applications
that are really helpful to biomedical research, so that researchers
can get more productive and make more progress in the informa-
tion rapid growing ear. To achieve the goal, more concerns should
be put on helping biological biomedical scientists to remove the
obstacles that block the development rather than discussions that
are not related with actual demands. One of the hottest topics of
text mining is to coordinate and cooperate with multiple subjects.
That is, biomedical text mining, coupled with other data and
means, should yield consistent, measurable, and testable results.
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